# A Study of JNJ-64281802 for the Prevention of Dengue Infection

> **NCT05201794** · PHASE2 · TERMINATED · sponsor: **Janssen Research & Development, LLC** · enrollment: 1595 (actual)

## Conditions studied

- Dengue

## Interventions

- **DRUG:** JNJ-64281802
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05201794
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-02-22
- **Primary completion:** 2024-06-26
- **Final completion:** 2024-06-26
- **Target enrollment:** 1595 (ACTUAL)
- **Why stopped:** The study was stopped due to portfolio reprioritization. This decision is not based on any safety concerns.
- **Last updated:** 2025-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05201794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05201794, "A Study of JNJ-64281802 for the Prevention of Dengue Infection". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05201794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*